Guardant Health Gets FDA Approval for Guardant360 CDx as Companion Diagnostic for Orserdu
By Chris Wack
Guardant Health Inc. said Monday that the US Food and Drug Administration has approved its Guardant360 CDx liquid biopsy test, to be marketed by Stemline Therapeutics Inc., a wholly owned subsidiary…